Cargando…
Exploring the efficacy of (18)F-FDG PET/CT in hepatocellular carcinoma diagnosis: role of Ki-67 index and tumor differentiation
PURPOSE: The sensitivity of [(18)F] fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG PET/CT) for detecting hepatocellular carcinoma (HCC) has not been clarified thoroughly. Our study seeks to explore the association between the Ki-67 index and FDG-avidity in HCC tumors...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556170/ https://www.ncbi.nlm.nih.gov/pubmed/37682282 http://dx.doi.org/10.1007/s00261-023-04027-4 |
_version_ | 1785116822261989376 |
---|---|
author | Yin, Yuping Liu, Jiachen Sun, Runlu Liu, Xuming Zhou, Zhangchi Zhang, Hong Li, Dan |
author_facet | Yin, Yuping Liu, Jiachen Sun, Runlu Liu, Xuming Zhou, Zhangchi Zhang, Hong Li, Dan |
author_sort | Yin, Yuping |
collection | PubMed |
description | PURPOSE: The sensitivity of [(18)F] fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG PET/CT) for detecting hepatocellular carcinoma (HCC) has not been clarified thoroughly. Our study seeks to explore the association between the Ki-67 index and FDG-avidity in HCC tumors using (18)F-FDG PET/CT. METHODS: 112 HCC lesions from 109 patients detected by (18)F-FDG PET/CT were included retrospectively between August 2017 and May 2022, comprising 82 lesions in the training cohort and 30 in the validation cohort to simulate prospective studies. In the training cohort, lesions were stratified by a lesion-to-liver maximum standardized uptake value (SUV(max)) ratio cut-off of 1.59. The relationships between lesion-to-liver SUV(max) ratios and several clinical factors including tumor differentiation, alpha fetoprotein (AFP), carcinoembryonic antigen (CEA), hepatitis B virus (HBV) infection, Ki-67 index et al. were assessed. These findings were subsequently validated in the independent validation cohort. RESULTS: In the training cohort, group A1 lesions demonstrated a higher Ki-67 index (%, 40.00 [30.00, 57.50] vs. 10.00 [5.00, 28.75], p<0.001) than group A0, the positive correlation between FDG-avidity and Ki-67 index was revealed by multivariate analysis, OR=1.040, 95% CI of OR [1.004–1.077], p=0.030. The calculated cut-off value was 17.5% using the receiver operating characteristic (ROC) curve, with an area under curve (AUC) of 0.834 and 95% CI [0.742–0.926], p<0.001. These findings were further validated in the independent validation cohort, with similar results (AUC=0.875, 95% CI [0.750–1.000], p<0.001). CONCLUSION: In comparison to tumor differentiation, Ki-67 index demonstrates a stronger association with FDG-avidity in HCC tumors, and when the Ki-67 index exceeds 17.5%, (18)F-FDG PET/CT might serve as a useful indicator for HCC. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-10556170 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-105561702023-10-07 Exploring the efficacy of (18)F-FDG PET/CT in hepatocellular carcinoma diagnosis: role of Ki-67 index and tumor differentiation Yin, Yuping Liu, Jiachen Sun, Runlu Liu, Xuming Zhou, Zhangchi Zhang, Hong Li, Dan Abdom Radiol (NY) Hepatobiliary PURPOSE: The sensitivity of [(18)F] fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG PET/CT) for detecting hepatocellular carcinoma (HCC) has not been clarified thoroughly. Our study seeks to explore the association between the Ki-67 index and FDG-avidity in HCC tumors using (18)F-FDG PET/CT. METHODS: 112 HCC lesions from 109 patients detected by (18)F-FDG PET/CT were included retrospectively between August 2017 and May 2022, comprising 82 lesions in the training cohort and 30 in the validation cohort to simulate prospective studies. In the training cohort, lesions were stratified by a lesion-to-liver maximum standardized uptake value (SUV(max)) ratio cut-off of 1.59. The relationships between lesion-to-liver SUV(max) ratios and several clinical factors including tumor differentiation, alpha fetoprotein (AFP), carcinoembryonic antigen (CEA), hepatitis B virus (HBV) infection, Ki-67 index et al. were assessed. These findings were subsequently validated in the independent validation cohort. RESULTS: In the training cohort, group A1 lesions demonstrated a higher Ki-67 index (%, 40.00 [30.00, 57.50] vs. 10.00 [5.00, 28.75], p<0.001) than group A0, the positive correlation between FDG-avidity and Ki-67 index was revealed by multivariate analysis, OR=1.040, 95% CI of OR [1.004–1.077], p=0.030. The calculated cut-off value was 17.5% using the receiver operating characteristic (ROC) curve, with an area under curve (AUC) of 0.834 and 95% CI [0.742–0.926], p<0.001. These findings were further validated in the independent validation cohort, with similar results (AUC=0.875, 95% CI [0.750–1.000], p<0.001). CONCLUSION: In comparison to tumor differentiation, Ki-67 index demonstrates a stronger association with FDG-avidity in HCC tumors, and when the Ki-67 index exceeds 17.5%, (18)F-FDG PET/CT might serve as a useful indicator for HCC. GRAPHICAL ABSTRACT: [Image: see text] Springer US 2023-09-08 2023 /pmc/articles/PMC10556170/ /pubmed/37682282 http://dx.doi.org/10.1007/s00261-023-04027-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Hepatobiliary Yin, Yuping Liu, Jiachen Sun, Runlu Liu, Xuming Zhou, Zhangchi Zhang, Hong Li, Dan Exploring the efficacy of (18)F-FDG PET/CT in hepatocellular carcinoma diagnosis: role of Ki-67 index and tumor differentiation |
title | Exploring the efficacy of (18)F-FDG PET/CT in hepatocellular carcinoma diagnosis: role of Ki-67 index and tumor differentiation |
title_full | Exploring the efficacy of (18)F-FDG PET/CT in hepatocellular carcinoma diagnosis: role of Ki-67 index and tumor differentiation |
title_fullStr | Exploring the efficacy of (18)F-FDG PET/CT in hepatocellular carcinoma diagnosis: role of Ki-67 index and tumor differentiation |
title_full_unstemmed | Exploring the efficacy of (18)F-FDG PET/CT in hepatocellular carcinoma diagnosis: role of Ki-67 index and tumor differentiation |
title_short | Exploring the efficacy of (18)F-FDG PET/CT in hepatocellular carcinoma diagnosis: role of Ki-67 index and tumor differentiation |
title_sort | exploring the efficacy of (18)f-fdg pet/ct in hepatocellular carcinoma diagnosis: role of ki-67 index and tumor differentiation |
topic | Hepatobiliary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556170/ https://www.ncbi.nlm.nih.gov/pubmed/37682282 http://dx.doi.org/10.1007/s00261-023-04027-4 |
work_keys_str_mv | AT yinyuping exploringtheefficacyof18ffdgpetctinhepatocellularcarcinomadiagnosisroleofki67indexandtumordifferentiation AT liujiachen exploringtheefficacyof18ffdgpetctinhepatocellularcarcinomadiagnosisroleofki67indexandtumordifferentiation AT sunrunlu exploringtheefficacyof18ffdgpetctinhepatocellularcarcinomadiagnosisroleofki67indexandtumordifferentiation AT liuxuming exploringtheefficacyof18ffdgpetctinhepatocellularcarcinomadiagnosisroleofki67indexandtumordifferentiation AT zhouzhangchi exploringtheefficacyof18ffdgpetctinhepatocellularcarcinomadiagnosisroleofki67indexandtumordifferentiation AT zhanghong exploringtheefficacyof18ffdgpetctinhepatocellularcarcinomadiagnosisroleofki67indexandtumordifferentiation AT lidan exploringtheefficacyof18ffdgpetctinhepatocellularcarcinomadiagnosisroleofki67indexandtumordifferentiation |